A detailed history of Ikarian Capital, LLC transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 78,574 shares of ITOS stock, worth $570,447. This represents 0.14% of its overall portfolio holdings.

Number of Shares
78,574
Previous 78,574 -0.0%
Holding current value
$570,447
Previous $1.17 Million 31.22%
% of portfolio
0.14%
Previous 0.47%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$10.33 - $18.09 $235,017 - $411,565
-22,751 Reduced 22.45%
78,574 $1.17 Million
Q1 2024

May 15, 2024

SELL
$9.89 - $13.64 $2.42 Million - $3.34 Million
-245,146 Reduced 70.76%
101,325 $1.38 Million
Q3 2023

Nov 14, 2023

BUY
$10.95 - $14.6 $3.79 Million - $5.06 Million
346,471 New
346,471 $3.79 Million

Others Institutions Holding ITOS

About iTeos Therapeutics, Inc.


  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $258M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.